Insight Molecular Diagnostics (IMDX) Intangibles (2020 - 2025)
Historic Intangibles for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to $15.0 million.
- Insight Molecular Diagnostics' Intangibles fell 7358.62% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year decrease of 7358.62%. This contributed to the annual value of $15.0 million for FY2024, which is 7358.62% down from last year.
- Per Insight Molecular Diagnostics' latest filing, its Intangibles stood at $15.0 million for Q3 2025, which was down 7358.62% from $15.0 million recorded in Q2 2025.
- In the past 5 years, Insight Molecular Diagnostics' Intangibles ranged from a high of $95.2 million in Q2 2021 and a low of $15.0 million during Q4 2024
- Its 5-year average for Intangibles is $56.1 million, with a median of $56.9 million in 2023.
- As far as peak fluctuations go, Insight Molecular Diagnostics' Intangibles skyrocketed by 53070.91% in 2021, and later crashed by 7358.62% in 2024.
- Quarter analysis of 5 years shows Insight Molecular Diagnostics' Intangibles stood at $61.9 million in 2021, then changed by 0.0% to $61.9 million in 2022, then fell by 8.0% to $56.9 million in 2023, then tumbled by 73.59% to $15.0 million in 2024, then changed by 0.0% to $15.0 million in 2025.
- Its last three reported values are $15.0 million in Q3 2025, $15.0 million for Q2 2025, and $15.0 million during Q1 2025.